Berger, Julia M.
Wohlfarth, Phillipp
Königsbrügge, Oliver
Knaus, Hanna A.
Porpaczy, Edit
Kaufmann, Hannes
Schreiber, Johanna
Mrva-Ghukasyan, Tatevik
Winder, Thomas
Severgnini, Luciano
Wolf, Dominik
Petzer, Verena
Nguyen, Van Anh
Weinlich, Georg
Öhler, Leopold
Wonnerth, Anna
Miksovsky, Aurelia
Engelhart, Bert
Preusser, Matthias
Berghoff, Anna S.
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 9 September 2021
Accepted: 16 January 2022
First Online: 16 February 2022
Conflict of interest
: M. Preusser has received fees for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen. The following for-profit companies have supported clinical trials and contracted research conducted by MP with payments made to his institution: Böhringer-Ingelheim, Bristol-Myers Squibb/Celgene, Novartis, Pfizer, Roche, Daiichi Sankyo, Merck Sharp & Dome, Novocure, GlaxoSmithKline, AbbVie, Star Therapeutics. A.S. Berghoff has research support from Daiichi Sankyo (≤ 10,000 €), Roche (> 10,000 €) and honoraria for lectures, consultation or advisory board participation from Roche Bristol-Meyers Squibb, Merck, Daiichi Sankyo (all < 5000 €) as well as travel support from Roche, Amgen and AbbVie. D. Wolf has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Pfizer, Bristol-Myers Squibb/Celgene, Novartis, Roche, Astra Zeneca, Takeda, Gilead, AbbVie, Lilly, Daiichi Sankyo, Sanofi, Merck Sharp & Dome.: T. Winder has received honoraria for lectures, consultation or advisory board participation from the following companies: Bristol-Myers Squibb, Novartis, Roche, Astra Zeneca, Lilly, Servier, Bayer, Medahead, Merck Sharp & Dome, Beupdated, Amgen. J.M. Berger, P. Wohlfarth, O. Königsbrügge, H.A. Knaus, E. Porpaczy, H. Kaufmann, J. Schreiber, T. Mrva-Ghukasyan, L. Severgnini, V. Petzer, V.A. Nguyen, G. Weinlich, L. Öhler, A. Wonnerth, A. Miksovsky and B. Engelhart declare that they have no competing interests.